2 Min Read
* Health stocks drop after Trump comments on drug pricing
* Dow up 0.02 pct, S&P down 0.23 pct, Nasdaq down 0.37 pct (Adds details on Trump speech, updates prices)
By Yashaswini Swamynathan
Jan 11 (Reuters) - U.S. stocks slipped on Wednesday, weighed down by healthcare stocks after President-elect Donald Trump commented on the need for competitive drug pricing in his first formal news conference after his victory.
Investors are closely watching Trump's speech, looking for clues on where his priorities as the new president lie, after taking office on Jan. 20 and how he plans boost economic growth.
Eight of the 11 major S&P sectors were lower. The healthcare sector dropped 0.787 percent after Trump said the country needs more competitive drug bidding.
He said pharmaceutical companies are "getting away with murder" by charging high drug prices.
Lockheed Martin dropped about 1 percent after Trump said the F-35 fighter jet project "is way behind schedule and billions over budget."
At 11:33 a.m. ET (1633 GMT), the Dow Jones Industrial Average was up 3.99 points, or 0.02 percent, at 19,859.52, the S&P 500 was down 5.26 points, or 0.23 percent, at 2,263.64 and the Nasdaq Composite was down 20.77 points, or 0.37 percent, at 5,531.05.
Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Savio D'Souza